ParinGenix Inc. Gets FDA Approval Of IND For PGX-100 
10/19/2005 5:12:39 PM

TUCSON, Ariz.--(BUSINESS WIRE)--Feb. 9, 2005--ParinGenix Inc., an early stage drug development company, has received approval of its Investigational New Drug (IND) application for its drug, PGX-100, from the U.S. Food and Drug Administration Division of Cardio-Renal Drug Products.